€
24.08
May 6
Business Description
Swedish Orphan Biovitrum AB
ISIN : SE0000872095
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.54 | |||||
Debt-to-EBITDA | 2.63 | |||||
Interest Coverage | 3.09 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.24 | |||||
Beneish M-Score | -2.49 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.5 | |||||
3-Year EBITDA Growth Rate | 1.1 | |||||
3-Year EPS without NRI Growth Rate | -2.5 | |||||
3-Year Book Growth Rate | 15.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | 33.09 | |||||
Future 3-5Y Total Revenue Growth Rate | 9.5 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 62.9 | |||||
9-Day RSI | 62.22 | |||||
14-Day RSI | 58.67 | |||||
6-1 Month Momentum % | 15.61 | |||||
12-1 Month Momentum % | 7.6 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.71 | |||||
Quick Ratio | 0.5 | |||||
Cash Ratio | 0.03 | |||||
Days Inventory | 254.68 | |||||
Days Sales Outstanding | 74.49 | |||||
Days Payable | 57.44 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.2 | |||||
Shareholder Yield % | -19.67 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 76.34 | |||||
Operating Margin % | 17.29 | |||||
Net Margin % | 9.26 | |||||
FCF Margin % | 10.09 | |||||
ROE % | 6.68 | |||||
ROA % | 3.03 | |||||
ROIC % | 4.37 | |||||
ROC (Joel Greenblatt) % | 904.75 | |||||
ROCE % | 7.17 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 44.18 | |||||
Forward PE Ratio | 27.7 | |||||
PE Ratio without NRI | 36.11 | |||||
Shiller PE Ratio | 37.33 | |||||
Price-to-Owner-Earnings | 41.06 | |||||
PEG Ratio | 4.75 | |||||
PS Ratio | 4.06 | |||||
PB Ratio | 2.65 | |||||
Price-to-Free-Cash-Flow | 41.99 | |||||
Price-to-Operating-Cash-Flow | 20 | |||||
EV-to-EBIT | 29.31 | |||||
EV-to-Forward-EBIT | 23.45 | |||||
EV-to-EBITDA | 15.6 | |||||
EV-to-Forward-EBITDA | 13.25 | |||||
EV-to-Revenue | 4.92 | |||||
EV-to-Forward-Revenue | 4.66 | |||||
EV-to-FCF | 49.25 | |||||
Price-to-Projected-FCF | 2.28 | |||||
Price-to-DCF (Earnings Based) | 2.58 | |||||
Price-to-DCF (FCF Based) | 3.01 | |||||
Price-to-Median-PS-Value | 0.8 | |||||
Earnings Yield (Greenblatt) % | 3.41 | |||||
FCF Yield % | 2.43 | |||||
Forward Rate of Return (Yacktman) % | 5.57 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Swedish Orphan Biovitrum AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 2,018.982 | ||
EPS (TTM) (€) | 0.56 | ||
Beta | 0.52 | ||
Volatility % | 30.53 | ||
14-Day RSI | 58.67 | ||
14-Day ATR (€) | 0.481992 | ||
20-Day SMA (€) | 22.837 | ||
12-1 Month Momentum % | 7.6 | ||
52-Week Range (€) | 16.129036 - 26.46 | ||
Shares Outstanding (Mil) | 339.87 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Swedish Orphan Biovitrum AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Swedish Orphan Biovitrum AB Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Swedish Orphan Biovitrum AB Frequently Asked Questions
What is Swedish Orphan Biovitrum AB(FRA:B6E)'s stock price today?
When is next earnings date of Swedish Orphan Biovitrum AB(FRA:B6E)?
Does Swedish Orphan Biovitrum AB(FRA:B6E) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |